| CAPE CORAL, Fla., Oct. 27, 2011 /PRNewswire/ -- Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV.pk) announced that it has reached an agreement with the inventor of a spectacular cold and flu medicine that has been in development for many years. The common cold, an infection of the upper respiratory tract, is caused by any of 200 different viruses. The viral infection and the immune system's battle against it produce the all-too-familiar symptoms: sore throat, nasal cong...continued MILV |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Thursday, October 27, 2011
Nature's Bioceuticals is Ready to Battle the Common Cold and Flu
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment